Risk factors for gliomas. An extensive review

Open access

Abstract

Primary brain tumors consist are a heterogenic group of malignancies. Gliomas represent subtypes which include all tumors arising from glial cells. The risk factors for gliomas are until today unclear. The aim of this study was to summarize all possible connections between suspected risk factors and glial brain tumors.

1.CBTRUS (Central Brain Tumor Registry of the United States) (2012). Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004-2008. Central Brain Tumor Registry of the United States.

2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010 Dec 15;127(12):2893-917.doi:10.1002/ijc.25516.

3.Wrensch M, Minn Y, Chew T, Bondy M, Berger MS. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol. 2002 Oct;4(4):278-99.

4.Ohgaki H, Kleihues P. Epidemiology and etiology of gliomas. Acta Neuropathol. 2005 Jan;109(1):93-108.

5.Bondy ML, Scheurer ME, Malmer B, Barnholtz- Sloan JS, Davis FG, Il'yasova D, Kruchko C, McCarthy BJ, Rajaraman P, Schwartzbaum JA, Sadetzki S, Schlehofer B, Tihan T, Wiemels JL, Wrensch M, Buffler PA; Brain Tumor Epidemiology Consortium. Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer. 2008 Oct 1;113(7 Suppl):1953-68

6.Iwamoto FM, Cooper AR, Reiner AS, Nayak L, Abrey LE. Glioblastoma in the elderly: the Memorial Sloan- Kettering Cancer Center Experience (1997-2007). Cancer. 2009 Aug 15;115(16):3758-66.

7.Verger E, Valduvieco I, Caral L, Pujol T, Ribalta T, Viñolas N, Boget T, Oleaga L, Blanco Y, Graus F. Does gender matter in glioblastoma? Clin Transl Oncol. 2011 Oct;13(10):737-41.

8.Kabat GC, Etgen AM, Rohan TE. Do steroid hormones play a role in the etiology of glioma? Cancer Epidemiol Biomarkers Prev. 2010 Oct;19(10):2421-7.

9.Cowppli-Bony A, Bouvier G, Rué M, Loiseau H, Vital A, Lebailly P, Fabbro-Peray P, Baldi I. Brain tumors and hormonal factors: review of the epidemiological literature. Cancer Causes Control. 2011 May;22(5):697-714.

10.Michaud DS, Gallo V, Schlehofer B, Tjønneland A, Olsen A, Overvad K, Dahm CC, Kaaks R, Lukanova A, Boeing H, Schütze M, Trichopoulou A, Bamia C, Kyrozis A, Sacerdote C, Agnoli C, Palli D, Tumino R, Mattiello A, Bueno-de-Mesquita HB, Ros MM, Peeters PH, van Gils CH, Lund E, Bakken K, Gram IT, Barricarte A, Navarro C, Dorronsoro M, Sánchez MJ, Rodríguez L, Duell EJ, Hallmans G, Melin BS, Manjer J, Borgquist S, Khaw KT, Wareham N, Allen NE, Tsilidis KK, Romieu I, Rinaldi S, Vineis P, Riboli E. Reproductive factors and exogenous hormone use in relation to risk of glioma and meningioma in a large European cohort study. Cancer Epidemiol Biomarkers Prev. 2010 Oct;19(10):2562-9.

11.Kabat GC, Park Y, Hollenbeck AR, Schatzkin A, Rohan TE. Reproductive factors and exogenous hormone use and risk of adult glioma in women in the NIH-AARP Diet and Health Study. Int J Cancer. 2011 Feb 15;128(4):944-50.

12.Wigertz A, Lönn S, Hall P, Auvinen A, Christensen HC, Johansen C, Klaeboe L, Salminen T, Schoemaker MJ, Swerdlow AJ, Tynes T, Feychting M. Reproductive factors and risk of meningioma and glioma. Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2663-70.

13.Benson VS, Pirie K, Green J, Bull D, Casabonne D, Reeves GK, Beral V; Million Women Study Collaborators. Hormone replacement therapy and incidence of central nervous system tumours in the Million Women Study. Int J Cancer. 2010 Oct 1;127(7):1692-8.

14.Wigertz A, Lönn S, Mathiesen T, Ahlbom A, Hall P, Feychting M; Swedish Interphone Study Group. Risk of brain tumors associated with exposure to exogenous female sex hormones. Am J Epidemiol. 2006 Oct 1;164(7):629-36.

15.Wrensch M, Lee M, Miike R, Newman B, Barger G, Davis R, Wiencke J, Neuhaus J. Familial and personal medical history of cancer and nervous system conditions among adults with glioma and controls. Am J Epidemiol. 1997 Apr 1;145(7):581-93.

16.Malmer B, Grönberg H, Bergenheim AT, Lenner P, Henriksson R. Familial aggregation of astrocytoma in northern Sweden: an epidemiological cohort study. Int J Cancer. 1999 May 5;81(3):366-70.

17.Malmer B, Henriksson R, Grönberg H. Familial brain tumours-genetics or environment? A nationwide cohort study of cancer risk in spouses and first-degree relatives of brain tumour patients. Int J Cancer. 2003 Aug 20;106(2):260-3.

18.Malmer B, Iselius L, Holmberg E, Collins A, Henriksson R, Grönberg H. Genetic epidemiology of glioma. Br J Cancer. 2001 Feb 2;84(3):429-34.

19.Malmer B, Haraldsson S, Einarsdottir E, Lindgren P, Holmberg D. Homozygosity mapping of familial glioma in Northern Sweden. Acta Oncol. 2005;44(2):114-9.

20.O'Neill BP, Blondal H, Yang P, Olafsdottir GH, Sigvaldason H, Jenkins RB, Kimmel DW, Scheithauer BW, Rocca WA, Bjornsson J, Tulinius H. Risk of cancer among relatives of patients with glioma. Cancer Epidemiol Biomarkers Prev. 2002 Sep;11(9):921-4.

21.Olivier M, Goldgar DE, Sodha N, Ohgaki H, Kleihues P, Hainaut P, Eeles RA. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. Cancer Res. 2003 Oct 15;63(20):6643-50.

22.Paunu N, Syrjäkoski K, Sankila R, Simola KO, Helén P, Niemelä M, Matikainen M, Isola J, Haapasalo H. Analysis of p53 tumor suppressor gene in families with multiple glioma patients. J Neurooncol. 2001 Dec;55(3):159-65.

23.Jasperson KW, Burt RW. APC-Associated Polyposis Conditions. 1998 Dec 18 (updated 2011 Oct 27). In: Pagon RA, Bird TD, Dolan CR, Stephens K, Adam MP, editors. GeneReviews™ (Internet). Seattle (WA): University of Washington, Seattle; 1993-. Available From http://www.ncbi.nlm.nih.gov/books/NBK1345/PubMed PMID: 20301519

24.Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, Bromberg JE, Hau P, Mirimanoff RO, Cairncross JG, Janzer RC, Stupp R. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005 Mar 10;352(10):997-1003.

25.Hegi ME, Diserens AC, Godard S, Dietrich PY, Regli L, Ostermann S, Otten P, Van Melle G, de Tribolet N, Stupp R. Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide. Clin Cancer Res. 2004 Mar 15;10(6):1871-4.

26.Lakomy R, Sana J, Hankeova S, Fadrus P, Kren L, Lzicarova E, Svoboda M, Dolezelova H, Smrcka M, Vyzula R, Michalek J, Hajduch M, Slaby O. MiR-195, miR-196b, miR-181c, miR-21 expression levels and O-6-methylguanine-DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patients. Cancer Sci. 2011 Dec;102(12):2186-90.

27.Liu Y, Scheurer ME, El-Zein R, Cao Y, Do KA, Gilbert M, Aldape KD, Wei Q, Etzel C, Bondy ML. Association and interactions between DNA repair gene polymorphisms and adult glioma. Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):204-14.

28.Zhou K, Hu D, Lu J, Fan W, Liu H, Chen H, Chen G, Wei Q, Du G, Mao Y, Lu D, Zhou L. A genetic variant in the APE1/Ref-1 gene promoter -141T/G may modulate risk of glioblastoma in a Chinese Han population. BMC Cancer. 2011 Mar 23;11:104.

29.Bethke L, Webb E, Murray A, Schoemaker M, Johansen C, Christensen HC, Muir K, McKinney P, Hepworth S, Dimitropoulou P, Lophatananon A, Feychting M, Lönn S, Ahlbom A, Malmer B, Henriksson R, Auvinen A, Kiuru A, Salminen T, Swerdlow A, Houlston R. Comprehensive analysis of the role of DNA repair gene polymorphisms on risk of glioma. Hum Mol Genet. 2008 Mar 15;17(6):800-5.

30.Chen P, Wiencke J, Aldape K, Kesler-Diaz A, Miike R, Kelsey K, Lee M, Liu J, Wrensch M. Association of an ERCC1 polymorphism with adult-onset glioma. Cancer Epidemiol Biomarkers Prev. 2000 Aug;9(8):843-7.

31.Wrensch M, Kelsey KT, Liu M, Miike R, Moghadassi M, Sison JD, Aldape K, McMillan A, Wiemels J, Wiencke JK. ERCC1 and ERCC2 polymorphisms and adult glioma. Neuro Oncol. 2005 Oct;7(4):495-507.

32.Chen H, Wang W, Xingjie Z, Song X, Fan W, Keke Z, Chen G, Zhao Y, Mao Y, Lu D. Association between genetic variations of vascular endothelial growth factor receptor 2 and glioma in the chinese han population. J Mol Neurosci. 2012 Jul;47(3):448-57. Epub 2012 Jan 25.

33.Wang SS, Hartge P, Yeager M, Carreón T, Ruder AM, Linet M, Inskip PD, Black A, Hsing AW, Alavanja M, Beane-Freeman L, Safaiean M, Chanock SJ, Rajaraman P. Joint associations between genetic variants and reproductive factors in glioma risk among women. Am J Epidemiol. 2011 Oct 15;174(8):901-8.

34.de Tayrac M, Aubry M, Saïkali S, Etcheverry A, Surbled C, Guénot F, Galibert MD, Hamlat A, Lesimple T, Quillien V, Menei P, Mosser J. A 4-gene signature associated with clinical outcome in high-grade gliomas. Clin Cancer Res. 2011 Jan 15;17(2):317-27.

35.Egan KM, Thompson RC, Nabors LB, Olson JJ, Brat DJ, Larocca RV, Brem S, Moots PL, Madden MH, Browning JE, Ann Chen Y. Cancer susceptibility variants and the risk of adult glioma in a US casecontrol study. J Neurooncol. 2011 Sep;104(2):535-42. Epub 2011 Jan 4. Erratum in: J Neurooncol. 2011 Sep;104(2):543.

36.Shintani T, Hayakawa N, Hoshi M, Sumida M, Kurisu K, Oki S, Kodama Y, Kajikawa H, Inai K, Kamada N. High incidence of meningioma among Hiroshima atomic bomb survivors. J Radiat Res. 1999 Mar;40(1):49-57.

37.Blettner M, Schlehofer B, Samkange-Zeeb F, Berg G, Schlaefer K, Schüz J. Medical exposure to ionising radiation and the risk of brain tumours: Interphone study group, Germany. Eur J Cancer. 2007 Sep;43(13):1990-8.

38.Davis F, Il'yasova D, Rankin K, McCarthy B, Bigner DD. Medical diagnostic radiation exposures and risk of gliomas. Radiat Res. 2011 Jun;175(6):790-6.

39.INTERPHONE Study Group. Brain tumour risk in relation to mobile telephone use: results of the INTERPHONE international case-control study. Int J Epidemiol. 2010 Jun;39(3):675-94. Epub 2010 May 17. Erratum in: Int J Epidemiol. 2012 Feb;41(1):328.

40.Hardell L, Carlberg M, Hansson Mild K. Re-analysis of risk for glioma in relation to mobile telephone use: comparison with the results of the Interphone international case-control study. Int J Epidemiol. 2011 Aug;40(4):1126-8.

41.Lönn S, Ahlbom A, Hall P, Feychting M; Swedish Interphone Study Group. Long-term mobile phone use and brain tumor risk. Am J Epidemiol. 2005 Mar 15;161(6):526-35.

42.Morgan L. Re: "Long-term mobile phone use and brain tumor risk". Am J Epidemiol. 2005 Sep 15;162(6):599-600; author reply 601.

43.Milham S. Re: "Long-term mobile phone use and brain tumor risk". Am J Epidemiol. 2005 Sep 15;162(6):599; author reply 601.

44.Hardell L, Mild KH, Kundi M. Re: "Long-term mobile phone use and brain tumor risk". Am J Epidemiol. 2005 Sep 15;162(6):600-1; author reply 601.

45.Hardell L, Carlberg M, Hansson Mild K. Pooled analysis of case-control studies on malignant brain tumours and the use of mobile and cordless phones including living and deceased subjects. Int J Oncol. 2011 May;38(5):1465-74

46.Hardell L, Carlberg M, Hansson Mild K. Mobile phone use and the risk for malignant brain tumors: a case-control study on deceased cases and controls. Neuroepidemiology. 2010 Aug;35(2):109-14

47.Hardell L, Carlberg M. Mobile phones, cordless phones and the risk for brain tumours. Int J Oncol. 2009 Jul;35(1):5-17.

48.Hardell L, Carlberg M, Hansson Mild K. Epidemiological evidence for an association between use of wireless phones and tumor diseases. Pathophysiology. 2009 Aug;16(2-3):113-22.

49.Hardell L, Carlberg M, Söderqvist F, Mild KH, Morgan LL. Long-term use of cellular phones and brain tumours: increased risk associated with use for > or =10 years. Occup Environ Med. 2007 Sep;64(9):626-32.

50.Cardis E, Armstrong BK, Bowman JD, Giles GG, Hours M, Krewski D, McBride M, Parent ME, Sadetzki S, Woodward A, Brown J, Chetrit A, Figuerola J, Hoffmann C, Jarus-Hakak A, Montestruq L, Nadon L, Richardson L, Villegas R, Vrijheid M. Risk of brain tumours in relation to estimated RF dose from mobile phones: results from five Interphone countries. Occup Environ Med. 2011 Sep;68(9):631-40

51.Frei P, Poulsen AH, Johansen C, Olsen JH, Steding- Jessen M, Schüz J. Use of mobile phones and risk of brain tumours: update of Danish cohort study. BMJ. 2011 Oct 19;343:d6387

52.Schüz J, Jacobsen R, Olsen JH, Boice JD Jr, McLaughlin JK, Johansen C. Cellular telephone use and cancer risk: update of a nationwide Danish cohort. J Natl Cancer Inst. 2006 Dec 6;98(23):1707-13

53.Johansen C, Boice J Jr, McLaughlin J, Olsen J. Cellular telephones and cancer--a nationwide cohort study in Denmark. J Natl Cancer Inst. 2001 Feb 7;93(3):203-7.

54.Hocking B. Re: cellular telephones and cancer--a nationwide cohort study in Denmark. J Natl Cancer Inst. 2001 Jun 6;93(11):877-8; author reply 878-9.

55.Godward S, Sandhu M, Skinner J, McCann J. Re: cellular telephones and cancer--a nationwide cohort study in Denmark. J Natl Cancer Inst. 2001 Jun 6;93(11):878; author reply 878-9.

56.Hardell L, Mild KH. Re: Cellular telephones and cancer--a nationwide cohort study in Denmark. J Natl Cancer Inst. 2001 Jun 20;93(12):952-3.

57.Baan R, Grosse Y, Lauby-Secretan B, El Ghissassi F, Bouvard V, Benbrahim-Tallaa L, Guha N, Islami F, Galichet L, Straif K; WHO International Agency for Research on Cancer Monograph Working Group. Carcinogenicity of radiofrequency electromagnetic fields. Lancet Oncol. 2011 Jul;12(7):624-6.

58.Little MP, Rajaraman P, Curtis RE, Devesa SS, Inskip PD, Check DP, Linet MS. Mobile phone use and glioma risk: comparison of epidemiological study results with incidence trends in the United States. BMJ. 2012 Mar 8;344:e1147.

59.Kundi M. The controversy about a possible relationship between mobile phone use and cancer. Environ Health Perspect. 2009 Mar;117(3):316-24

60.Benson VS, Pirie K, Green J, Casabonne D, Beral V; Million Women Study Collaborators. Lifestyle factors and primary glioma and meningioma tumours in the Million Women Study cohort. Br J Cancer. 2008 Jul 8;99(1):185-90.

61.Hu J, La Vecchia C, Negri E, Chatenoud L, Bosetti C, Jia X, Liu R, Huang G, Bi D, Wang C. Diet and brain cancer in adults: a case-control study in northeast China. Int J Cancer. 1999 Mar 31;81(1):20-3.

62.Blowers L, Preston-Martin S, Mack WJ. Dietary and other lifestyle factors of women with brain gliomas in Los Angeles County (California, USA). Cancer Causes Control. 1997 Jan;8(1):5-12.

63.Terry MB, Howe G, Pogoda JM, Zhang FF, Ahlbom A, Choi W, Giles GG, Little J, Lubin F, Menegoz F, Ryan P, Schlehofer B, Preston-Martin S. An international case-control study of adult diet and brain tumor risk: a histology-specific analysis by food group. Ann Epidemiol. 2009 Mar;19(3):161-71.

64.Holick CN, Smith SG, Giovannucci E, Michaud DS. Coffee, tea, caffeine intake, and risk of adult glioma in three prospective cohort studies. Cancer Epidemiol Biomarkers Prev. 2010 Jan;19(1):39-47.

65.Michaud DS, Gallo V, Schlehofer B, Tjønneland A, Olsen A, Overvad K, Dahm CC, Teucher B, Lukanova A, Boeing H, Schütze M, Trichopoulou A, Lagiou P, Kyrozis A, Sacerdote C, Krogh V, Masala G, Tumino R, Mattiello A, Bueno-de-Mesquita HB, Ros MM, Peeters PH, van Gils CH, Skeie G, Engeset D, Parr CL, Ardanaz E, Chirlaque MD, Dorronsoro M, Sánchez MJ, Argüelles M, Jakszyn P, Nilsson LM, Melin BS, Manjer J, Wirfält E, Khaw KT, Wareham N, Allen NE, Key TJ, Romieu I, Vineis P, Riboli E. Coffee and tea intake and risk of brain tumors in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study. Am J Clin Nutr. 2010 Nov;92(5):1145-50.

66.Kyritsis AP, Bondy ML, Levin VA. Modulation of glioma risk and progression by dietary nutrients and antiinflammatory agents. Nutr Cancer. 2011;63(2):174-84. Review.

67.Trouillas P, Honnorat J, Bret P, Jouvet A, Gerard JP. Redifferentiation therapy in brain tumors: long-lasting complete regression of glioblastomas and an anaplastic astrocytoma under long term 1-alphahydroxycholecalciferol. J Neurooncol. 2001 Jan;51(1):57-66.

68.Tedeschi-Blok N, Schwartzbaum J, Lee M, Miike R, Wrensch M; San Francisco Bay Area Adult Glioma Study. Dietary calcium consumption and astrocytic glioma: the San Francisco Bay Area Adult Glioma Study, 1991-1995. Nutr Cancer. 2001;39(2):196-203

69.Franklin RB, Costello LC. The important role of the apoptotic effects of zinc in the development of cancers. J Cell Biochem. 2009 Apr 1;106(5):750-7. Review.

70.Hogervorst JG, Schouten LJ, Konings EJ, Goldbohm RA, van den Brandt PA. Dietary acrylamide intake and brain cancer risk. Cancer Epidemiol Biomarkers Prev. 2009 May;18(5):1663-6

71.Chambless LB, Parker SL, Hassam-Malani L, McGirt MJ, Thompson RC. Type 2 diabetes mellitus and obesity are independent risk factors for poor outcome in patients with high-grade glioma. J Neurooncol. 2012 Jan;106(2):383-9.

72.Derr RL, Ye X, Islas MU, Desideri S, Saudek CD, Grossman SA. Association between hyperglycemia and survival in patients with newly diagnosed glioblastoma. J Clin Oncol. 2009 Mar 1;27(7):1082-6.

73.Jones LW, Ali-Osman F, Lipp E, Marcello JE, McCarthy B, McCoy L, Rice T, Wrensch M, Il'yasova D. Association between body mass index and mortality in patients with glioblastoma mutliforme. Cancer Causes Control. 2010 Dec;21(12):2195-201.

74.Seyfried BT, Kiebish M, Marsh J, Mukherjee P. Targeting energy metabolism in brain cancer through calorie restriction and the ketogenic diet. J Cancer Res Ther. 2009 Sep;5 Suppl 1:S7-15. Review

75.Mukherjee P, El-Abbadi MM, Kasperzyk JL, Ranes MK, Seyfried TN. Dietary restriction reduces angiogenesis and growth in an orthotopic mouse brain tumour model. Br J Cancer. 2002 May 20;86(10):1615-21.

76.Mukherjee P, Abate LE, Seyfried TN. Antiangiogenic and proapoptotic effects of dietary restriction on experimental mouse and human brain tumors. Clin Cancer Res. 2004 Aug 15;10(16):5622-9.

77.Maurer GD, Brucker DP, Bähr O, Harter PN, Hattingen E, Walenta S, Mueller-Klieser W, Steinbach JP, Rieger J. Differential utilization of ketone bodies by neurons and glioma cell lines: a rationale for ketogenic diet as experimental glioma therapy. BMC Cancer. 2011 Jul 26;11:315.

78.Abdelwahab MG, Fenton KE, Preul MC, Rho JM, Lynch A, Stafford P, Scheck AC. The ketogenic diet is an effective adjuvant to radiation therapy for the treatment of malignant glioma. PLoS One. 2012;7(5):e36197

79.Mukherjee P, Mulrooney TJ, Marsh J, Blair D, Chiles TC, Seyfried TN. Differential effects of energy stress on AMPK phosphorylation and apoptosis in experimental brain tumor and normal brain. Mol Cancer. 2008 May 12;7:37.

80.Fisher JL, Schwartzbaum JA, Wrensch M, Wiemels JL. Epidemiology of brain tumors. Neurol Clin. 2007 Nov;25(4):867-90, vii. Review. PubMed PMID: 17964019.

81.Baglietto L, Giles GG, English DR, Karahalios A, Hopper JL, Severi G. Alcohol consumption and risk of glioblastoma; evidence from the Melbourne Collaborative Cohort Study. Int J Cancer. 2011 Apr 15;128(8):1929-34.

82.Hurley SF, McNeil JJ, Donnan GA, Forbes A, Salzberg M, Giles GG. Tobacco smoking and alcohol consumption as risk factors for glioma: a case-control study in Melbourne, Australia. J Epidemiol Community Health. 1996 Aug;50(4):442-6.

83.DeVito WJ, Stone S, Mori K, Shamgochian M. Ethanol inhibits prolactin- and tumor necrosis factoralpha-, but not gamma interferon-induced expression of intercellular adhesion molecule-1 in human astrocytoma cells. J Cell Biochem. 2000 Apr;77(3):455-64.

84.Efird JT, Friedman GD, Sidney S, Klatsky A, Habel LA, Udaltsova NV, Van den Eeden S, Nelson LM. The risk for malignant primary adult-onset glioma in a large, multiethnic, managed-care cohort: cigarette smoking and other lifestyle behaviors. J Neurooncol. 2004 May;68(1):57-69.

85.Tulinius H, Sigfússon N, Sigvaldason H, Bjarnadóttir K, Tryggvadóttir L. Risk factors for malignant diseases: a cohort study on a population of 22,946 Icelanders. Cancer Epidemiol Biomarkers Prev. 1997 Nov;6(11):863-73.

86.Holick CN, Giovannucci EL, Rosner B, Stampfer MJ, Michaud DS. Prospective study of cigarette smoking and adult glioma: dosage, duration, and latency. Neuro Oncol. 2007 Jul;9(3):326-34.

87.Lachance DH, Yang P, Johnson DR, Decker PA, Kollmeyer TM, McCoy LS, Rice T, Xiao Y, Ali-Osman F, Wang F, Stoddard SM, Sprau DJ, Kosel ML, Wiencke JK, Wiemels JL, Patoka JS, Davis F, McCarthy B, Rynearson AL, Worra JB, Fridley BL, O'Neill BP, Buckner JC, Il'yasova D, Jenkins RB, Wrensch MR. Associations of high-grade glioma with glioma risk alleles and histories of allergy and smoking. Am J Epidemiol. 2011 Sep 1;174(5):574-81.

88.Mandelzweig L, Novikov I, Sadetzki S. Smoking and risk of glioma: a meta-analysis. Cancer Causes Control. 2009 Dec;20(10):1927-38.

89.Silvera SA, Miller AB, Rohan TE. Cigarette smoking and risk of glioma: a prospective cohort study. Int J Cancer. 2006 Apr 1;118(7):1848-51

90.Cogliano VJ, Baan R, Straif K, Grosse Y, Lauby- Secretan B, El Ghissassi F, Bouvard V, Benbrahim- Tallaa L, Guha N, Freeman C, Galichet L, Wild CP. Preventable exposures associated with human cancers. J Natl Cancer Inst. 2011 Dec 21;103(24):1827-39. Epub 2011 Dec 12. Review

91.Hashibe M, Straif K, Tashkin DP, Morgenstern H, Greenland S, Zhang ZF. Epidemiologic review of marijuana use and cancer risk. Alcohol. 2005 Apr;35(3):265-75. Review.

92.Torres S, Lorente M, Rodríguez-Fornés F, Hernández-Tiedra S, Salazar M, García-Taboada E, Barcia J, Guzmán M, Velasco G. A combined preclinical therapy of cannabinoids and temozolomide against glioma. Mol Cancer Ther. 2011 Jan;10(1):90-103

93.Foroughi M, Hendson G, Sargent MA, Steinbok P. Spontaneous regression of septum pellucidum/forniceal pilocytic astrocytomas--possible role of Cannabis inhalation. Childs Nerv Syst. 2011 Apr;27(4):671-9.

94.Wiemels JL, Wiencke JK, Sison JD, Miike R, McMillan A, Wrensch M. History of allergies among adults with glioma and controls. Int J Cancer. 2002 Apr 1;98(4):609-15.

95.Schlehofer B, Blettner M, Preston-Martin S, Niehoff D, Wahrendorf J, Arslan A, Ahlbom A, Choi WN, Giles GG, Howe GR, Little J, Ménégoz F, Ryan P. Role of medical history in brain tumour development. Results from the international adult brain tumour study. Int J Cancer. 1999 Jul 19;82(2):155-60.

96.Brenner AV, Linet MS, Fine HA, Shapiro WR, Selker RG, Black PM, Inskip PD. History of allergies and autoimmune diseases and risk of brain tumors in adults. Int J Cancer. 2002 May 10;99(2):252-9.

97.Schwartzbaum J, Jonsson F, Ahlbom A, Preston- Martin S, Lönn S, Söderberg KC, Feychting M. Cohort studies of association between self-reported allergic conditions, immune-related diagnoses and glioma and meningioma risk. Int J Cancer. 2003 Sep 1;106(3):423-8. Review.

98.Il'yasova D, McCarthy B, Marcello J, Schildkraut JM, Moorman PG, Krishnamachari B, Ali-Osman F, Bigner DD, Davis F. Association between glioma and history of allergies, asthma, and eczema: a case-control study with three groups of controls. Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1232-8.

99.Berg-Beckhoff G, Schüz J, Blettner M, Münster E, Schlaefer K, Wahrendorf J, Schlehofer B. History of allergic disease and epilepsy and risk of glioma and meningioma (INTERPHONE study group, Germany). Eur J Epidemiol. 2009;24(8):433-40.

100.Wiemels JL, Wilson D, Patil C, Patoka J, McCoy L, Rice T, Schwartzbaum J, Heimberger A, Sampson JH, Chang S, Prados M, Wiencke JK, Wrensch M. IgE, allergy, and risk of glioma: update from the San Francisco Bay Area Adult Glioma Study in the temozolomide era. Int J Cancer. 2009 Aug 1;125(3):680-7

101.McCarthy BJ, Rankin K, Il'yasova D, Erdal S, Vick N, Ali-Osman F, Bigner DD, Davis F. Assessment of type of allergy and antihistamine use in the development of glioma. Cancer Epidemiol Biomarkers Prev. 2011 Feb;20(2):370-8.

102.Chen C, Xu T, Chen J, Zhou J, Yan Y, Lu Y, Wu S. Allergy and risk of glioma: a meta-analysis. Eur J Neurol. 2011 Mar;18(3):387-95. doi: 10.1111/j.1468-1331.2010.03187.x. Epub 2010 Aug 16

103.Wiemels JL, Wiencke JK, Patoka J, Moghadassi M, Chew T, McMillan A, Miike R, Barger G, Wrensch M. Reduced immunoglobulin E and allergy among adults with glioma compared with controls. Cancer Res. 2004 Nov 15;64(22):8468-73.

104.Calboli FC, Cox DG, Buring JE, Gaziano JM, Ma J, Stampfer M, Willett WC, Tworoger SS, Hunter DJ, Camargo CA Jr, Michaud DS. Prediagnostic plasma IgE levels and risk of adult glioma in four prospective cohort studies. J Natl Cancer Inst. 2011 Nov 2;103(21):1588-95.

105.Schlehofer B, Siegmund B, Linseisen J, Schüz J, Rohrmann S, Becker S, Michaud D, Melin B, Bas Bueno-de-Mesquita H, Peeters PH, Vineis P, Tjonneland A, Olsen A, Overvad K, Romieu I, Boeing H, Aleksandrova K, Trichopoulou A, Bamia C, Lagiou P, Sacerdote C, Palli D, Panico S, Sieri S, Tumino R, Sanchez MJ, Rodriguez L, Dorronsoro M, Duell EJ, Chirlaque MD, Barricarte A, Borgquist S, Manjer J, Gallo V, Allen NE, Key TJ, Riboli E, Kaaks R, Wahrendorf J. Primary brain tumours and specific serum immunoglobulin E: a case-control study nested in the European Prospective Investigation into Cancer and Nutrition cohort. Allergy. 2011 Nov;66(11):1434-41.

106.Curran CS, Bertics PJ. Eosinophils in glioblastoma biology. J Neuroinflammation. 2012 Jan 17;9:11. Review.

107.Zhou M, Wiemels JL, Bracci PM, Wrensch MR, McCoy LS, Rice T, Sison JD, Patoka JS, Wiencke JK. Circulating levels of the innate and humoral immune regulators CD14 and CD23 are associated with adult glioma. Cancer Res. 2010 Oct 1;70(19):7534-42.

108.Schwartzbaum J, Ahlbom A, Malmer B, Lönn S, Brookes AJ, Doss H, Debinski W, Henriksson R, Feychting M. Polymorphisms associated with asthma are inversely related to glioblastoma multiforme. Cancer Res. 2005 Jul 15;65(14):6459-65.

109.Wrensch M, Wiencke JK, Wiemels J, Miike R, Patoka J, Moghadassi M, McMillan A, Kelsey KT, Aldape K, Lamborn KR, Parsa AT, Sison JD, Prados MD. Serum IgE, tumor epidermal growth factor receptor expression, and inherited polymorphisms associated with glioma survival. Cancer Res. 2006 Apr 15;66(8):4531-41.

110.White MK, Gordon J, Reiss K, Del Valle L, Croul S, Giordano A, Darbinyan A, Khalili K. Human polyomaviruses and brain tumors. Brain Res Brain Res Rev. 2005 Dec 1;50(1):69-85. Epub 2005 Jun 27. Review.

111.Rollison DE, Helzlsouer KJ, Alberg AJ, Hoffman S, Hou J, Daniel R, Shah KV, Major EO. Serum antibodies to JC virus, BK virus, simian virus 40, and the risk of incident adult astrocytic brain tumors. Cancer Epidemiol Biomarkers Prev. 2003 May;12(5):460-3.

112.Sjöström S, Hjalmars U, Juto P, Wadell G, Hallmans G, Tjönneland A, Halkjaer J, Manjer J, Almquist M, Melin BS. Human immunoglobulin G levels of viruses and associated glioma risk. Cancer Causes Control. 2011 Sep;22(9):1259-66.

113.Hill DA, Inskip PD, Shapiro WR, Selker RG, Fine HA, Black PM, Linet MS. Cancer in first-degree relatives and risk of glioma in adults. Cancer Epidemiol Biomarkers Prev. 2003 Dec;12(12):1443-8.

114.Hemminki K, Li X, Collins VP. Parental cancer as a risk factor for brain tumors (Sweden). Cancer Causes Control. 2001 Apr;12(3):195-9.

115.McCarthy BJ, Rankin KM, Aldape K, Bondy ML, Brännström T, Broholm H, Feychting M, Il'yasova D, Inskip PD, Johansen C, Melin BS, Ruder AM, Butler MA, Scheurer ME, Schüz J, Schwartzbaum JA, Wrensch MR, Davis FG. Risk factors for oligodendroglial tumors: a pooled international study. Neuro Oncol. 2011 Feb;13(2):242-50.

116.Sivak-Sears NR, Schwartzbaum JA, Miike R, Moghadassi M, Wrensch M. Case-control study of use of nonsteroidal antiinflammatory drugs and glioblastoma multiforme. Am J Epidemiol. 2004 Jun 15;159(12):1131-9.

117.Scheurer ME, El-Zein R, Thompson PA, Aldape KD, Levin VA, Gilbert MR, Weinberg JS, Bondy ML. Long-term anti-inflammatory and antihistamine medication use and adult glioma risk. Cancer Epidemiol Biomarkers Prev. 2008 May;17(5):1277-81. doi: 10.1158/1055-9965.EPI-07-2621

118.Samkange-Zeeb F, Schlehofer B, Schüz J, Schlaefer K, Berg-Beckhoff G, Wahrendorf J, Blettner M. Occupation and risk of glioma, meningioma and acoustic neuroma: results from a German case-control study (interphone study group, Germany). Cancer Epidemiol. 2010 Feb;34(1):55-61.

119.Carozza SE, Wrensch M, Miike R, Newman B, Olshan AF, Savitz DA, Yost M, Lee M. Occupation and adult gliomas. Am J Epidemiol. 2000 Nov 1;152(9):838-46.

120.Cordier S, Mandereau L, Preston-Martin S, Little J, Lubin F, Mueller B, Holly E, Filippini G, Peris-Bonet R, McCredie M, Choi NW, Arsla A. Parental occupations and childhood brain tumors: results of an international case-control study. Cancer Causes Control. 2001 Nov;12(9):865-74.

121.Rosso AL, Hovinga ME, Rorke-Adams LB, Spector LG, Bunin GR; Children's Oncology Group. A casecontrol study of childhood brain tumors and fathers' hobbies: a Children's Oncology Group study. Cancer Causes Control. 2008 Dec;19(10):1201-7.

122.Hardell L. Pesticides, soft-tissue sarcoma and non- Hodgkin lymphoma--historical aspects on the precautionary principle in cancer prevention. Acta Oncol. 2008;47(3):347-54.

123.Samanic CM, De Roos AJ, Stewart PA, Rajaraman P, Waters MA, Inskip PD. Occupational exposure to pesticides and risk of adult brain tumors. Am J Epidemiol. 2008 Apr 15;167(8):976-85.

124.Bhat AR, Wani MA, Kirmani AR. Brain cancer and pesticide relationship in orchard farmers of Kashmir. Indian J Occup Environ Med. 2010 Sep;14(3):78-86.

125.Ruder AM, Carreón T, Butler MA, Calvert GM, Davis-King KE, Waters MA, Schulte PA, Mandel JS, Morton RF, Reding DJ, Rosenman KD; Brain Cancer Collaborative Study Group. Exposure to farm crops, livestock, and farm tasks and risk of glioma: the Upper Midwest Health Study. Am J Epidemiol. 2009 Jun 15;169(12):1479-91.

126.Rajaraman P, Stewart PA, Samet JM, Schwartz BS, Linet MS, Zahm SH, Rothman N, Yeager M, Fine HA, Black PM, Loeffler J, Shapiro WR, Selker RG, Inskip PD. Lead, genetic susceptibility, and risk of adult brain tumors. Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2514-20.

127.De Roos AJ, Stewart PA, Linet MS, Heineman EF, Dosemeci M, Wilcosky T, Shapiro WR, Selker RG, Fine HA, Black PM, Inskip PD. Occupation and the risk of adult glioma in the United States. Cancer Causes Control. 2003 Mar;14(2):139-50.

128.Cabaniols C, Giorgi R, Chinot O, Ferahta N, Spinelli V, Alla P, Barrie M, Lehucher-Michel MP. Links between private habits, psychological stress and brain cancer: a case-control pilot study in France. J Neurooncol. 2011 Jun;103(2):307-16.

129.Inskip PD, Tarone RE, Hatch EE, Wilcosky TC, Fine HA, Black PM, Loeffler JS, Shapiro WR, Selker RG, Linet MS. Sociodemographic indicators and risk of brain tumours. Int J Epidemiol. 2003 Apr;32(2):225-33.

130.Preston-Martin S, Pogoda JM, Schlehofer B, Blettner M, Howe GR, Ryan P, Menegoz F, Giles GG, Rodvall Y, Choi NW, Little J, Arslan A. An international case-control study of adult glioma and meningioma: the role of head trauma. Int J Epidemiol. 1998 Aug;27(4):579-86.

131.Inskip PD, Mellemkjaer L, Gridley G, Olsen JH. Incidence of intracranial tumors following hospitalization for head injuries (Denmark). Cancer Causes Control. 1998 Jan;9(1):109-16.

132.Zhou B, Liu W. Post-traumatic glioma: report of one case and review of the literature. Int J Med Sci. 2010 Jul 29;7(5):248-50. Review.

133.Bluhm EC, Zahm SH, Fine HA, Black PM, Loeffler JS, Shapiro WR, Selker RG, Inskip PD. Personal hair dye use and risks of glioma, meningioma, and acoustic neuroma among adults. Am J Epidemiol. 2007 Jan 1;165(1):63-71.

134.Harder T, Plagemann A, Harder A. Birth weight and subsequent risk of childhood primary brain tumors: a meta-analysis. Am J Epidemiol. 2008 Aug 15;168(4):366-73.

135.Efird JT. Season of birth and risk for adult onset glioma. Int J Environ Res Public Health. 2010 May;7(5):1913-36.

Romanian Neurosurgery

The Journal of Romanian Society of Neurosurgery

Journal Information

Cited By

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 264 149 16
PDF Downloads 111 74 5